119 related articles for article (PubMed ID: 38153233)
1. Cellular Ligand-Receptor Perturbations Unravel MEIS2 as a Key Factor for the Aggressive Progression and Prognosis in Stage II/III Colorectal Cancer.
Xu H; Chen S; Li J; Weng S; Ren Y; Zhang Y; Wang L; Liu L; Guo C; Xing Z; Luo P; Cheng Q; Han X; Liu Z
J Proteome Res; 2024 Feb; 23(2):760-774. PubMed ID: 38153233
[TBL] [Abstract][Full Text] [Related]
2. MEIS2 promotes cell migration and invasion in colorectal cancer.
Wan Z; Chai R; Yuan H; Chen B; Dong Q; Zheng B; Mou X; Pan W; Tu Y; Yang Q; Tu S; Hu X
Oncol Rep; 2019 Jul; 42(1):213-223. PubMed ID: 31115559
[TBL] [Abstract][Full Text] [Related]
3. RNA sequencing reveals PNN and KCNQ1OT1 as predictive biomarkers of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy.
Mini E; Lapucci A; Perrone G; D'Aurizio R; Napoli C; Brugia M; Landini I; Tassi R; Picariello L; Simi L; Mancini I; Messerini L; Magi A; Pinzani P; Mazzei T; Tonelli F; Nobili S
Int J Cancer; 2019 Nov; 145(9):2580-2593. PubMed ID: 30973654
[TBL] [Abstract][Full Text] [Related]
4. Identification and Construction of Combinatory Cancer Hallmark-Based Gene Signature Sets to Predict Recurrence and Chemotherapy Benefit in Stage II Colorectal Cancer.
Gao S; Tibiche C; Zou J; Zaman N; Trifiro M; O'Connor-McCourt M; Wang E
JAMA Oncol; 2016 Jan; 2(1):37-45. PubMed ID: 26502222
[TBL] [Abstract][Full Text] [Related]
5. The prognostic value of KRAS and BRAF in stage I-III colorectal cancer. A systematic review.
Gallo G; Sena G; Vescio G; Papandrea M; Sacco R; Trompetto M; Sammarco G
Ann Ital Chir; 2019; 90():127-137. PubMed ID: 30739887
[TBL] [Abstract][Full Text] [Related]
6. A network-based predictive gene expression signature for recurrence risks in stage II colorectal cancer.
Yang WJ; Wang HB; Wang WD; Bai PY; Lu HX; Sun CH; Liu ZS; Guan DK; Yang GW; Zhang GL
Cancer Med; 2020 Jan; 9(1):179-193. PubMed ID: 31724326
[TBL] [Abstract][Full Text] [Related]
7. Methylated septin 9 gene is an important prognostic marker in stage II and stage III colorectal cancer for evaluating local recurrence or distant metastasis after surgery.
Huang M; He J; Lai W; Liu L; Xu H; Zeng Y; Lan Q; Lin X; Chu Z
BMC Gastroenterol; 2022 Feb; 22(1):87. PubMed ID: 35227194
[TBL] [Abstract][Full Text] [Related]
8. Lysosomal acid phosphatase 2 is an unfavorable prognostic factor but is associated with better survival in stage II colorectal cancer patients receiving chemotherapy.
Lee YC; Su CY; Lin YF; Lin CM; Fang CY; Lin YK; Hsiao M; Chen CL
Oncotarget; 2017 Feb; 8(7):12120-12132. PubMed ID: 28076332
[TBL] [Abstract][Full Text] [Related]
9. MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside.
To KK; Tong CW; Wu M; Cho WC
World J Gastroenterol; 2018 Jul; 24(27):2949-2973. PubMed ID: 30038463
[TBL] [Abstract][Full Text] [Related]
10. CINSARC signature outperforms gold-standard TNM staging and consensus molecular subtypes for clinical outcome in stage II-III colorectal carcinoma.
Brunac AC; Fourquet J; Perot G; Jaffrelot M; Meilleroux J; Danjoux M; Filleron T; Nicolaï V; Guimbaud R; Icher S; Farés N; Selves J; Chibon F
Mod Pathol; 2022 Dec; 35(12):2002-2010. PubMed ID: 36202996
[TBL] [Abstract][Full Text] [Related]
11. A novel mesenchymal-associated transcriptomic signature for risk-stratification and therapeutic response prediction in colorectal cancer.
Matsuyama T; Kandimalla R; Ishikawa T; Takahashi N; Yamada Y; Yasuno M; Kinugasa Y; Hansen TF; Fakih M; Uetake H; Győrffy B; Goel A
Int J Cancer; 2020 Dec; 147(11):3250-3261. PubMed ID: 32657428
[TBL] [Abstract][Full Text] [Related]
12. NKX6.1 hypermethylation predicts the outcome of stage II colorectal cancer patients undergoing chemotherapy.
Chang SY; Kuo CC; Wu CC; Hsiao CW; Hu JM; Hsu CH; Chou YC; Shih YL; Lin YW
Genes Chromosomes Cancer; 2018 May; 57(5):268-277. PubMed ID: 29363224
[TBL] [Abstract][Full Text] [Related]
13. Clinical Prognostic Significance of HOXC9 Expression in Patients with Colorectal Cancer.
Hu M; Ou-Yang W; Jing D; Chen R
Clin Lab; 2019 Aug; 65(8):. PubMed ID: 31414766
[TBL] [Abstract][Full Text] [Related]
14. Correlations between TBL1XR1 and recurrence of colorectal cancer.
Liu H; Xu Y; Zhang Q; Li K; Wang D; Li S; Ning S; Yang H; Shi W; Liu Z; Chen Y
Sci Rep; 2017 Mar; 7():44275. PubMed ID: 28295012
[TBL] [Abstract][Full Text] [Related]
15. Molecular subtyping of colorectal cancer: Recent progress, new challenges and emerging opportunities.
Wang W; Kandimalla R; Huang H; Zhu L; Li Y; Gao F; Goel A; Wang X
Semin Cancer Biol; 2019 Apr; 55():37-52. PubMed ID: 29775690
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of SNORA42 as an oncogene and a prognostic biomarker in colorectal cancer.
Okugawa Y; Toiyama Y; Toden S; Mitoma H; Nagasaka T; Tanaka K; Inoue Y; Kusunoki M; Boland CR; Goel A
Gut; 2017 Jan; 66(1):107-117. PubMed ID: 26475630
[TBL] [Abstract][Full Text] [Related]
17. Sidedness Matters: Surrogate Biomarkers Prognosticate Colorectal Cancer upon Anatomic Location.
Ben-Aharon I; Goshen-Lago T; Sternschuss M; Morgenstern S; Geva R; Beny A; Dror Y; Steiner M; Hubert A; Idelevich E; Shulman K; Mishaeli M; Man S; Liebermann N; Soussan-Gutman L; Brenner B
Oncologist; 2019 Aug; 24(8):e696-e701. PubMed ID: 30755502
[TBL] [Abstract][Full Text] [Related]
18. An immune, stroma, and epithelial-mesenchymal transition-related signature for predicting recurrence and chemotherapy benefit in stage II-III colorectal cancer.
Cai D; Wang W; Zhong ME; Fan D; Liu X; Li CH; Huang ZP; Zhu Q; Lv MY; Hu C; Duan X; Wu XJ; Gao F
Cancer Med; 2023 Apr; 12(7):8924-8936. PubMed ID: 36629124
[TBL] [Abstract][Full Text] [Related]
19. miR-34a-5p suppresses colorectal cancer metastasis and predicts recurrence in patients with stage II/III colorectal cancer.
Gao J; Li N; Dong Y; Li S; Xu L; Li X; Li Y; Li Z; Ng SS; Sung JJ; Shen L; Yu J
Oncogene; 2015 Jul; 34(31):4142-52. PubMed ID: 25362853
[TBL] [Abstract][Full Text] [Related]
20. Delineation of colorectal cancer ligand-receptor interactions and their roles in the tumor microenvironment and prognosis.
Lin H; Xia L; Lian J; Chen Y; Zhang Y; Zhuang Z; Cai H; You J; Guan G
J Transl Med; 2021 Dec; 19(1):497. PubMed ID: 34876143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]